Global Epidemiology of Nontuberculous Mycobacterial Pulmonary Disease: A Review

被引:38
作者
Prevots, D. Rebecca [1 ]
Marshall, Julia E. [1 ]
Wagner, Dirk [2 ]
Morimoto, Kozo [3 ]
机构
[1] NIAID, Div Intramural Res, Epidemiol & Populat Studies Unit, NIH, 5601 Fishers Lane, Bethesda, MD 20852 USA
[2] Univ Freiburg, Fac Med, Med Ctr, Dept Internal Med 2,Div Infect Dis, Hugstetter St 55, b106, Freiburg, Germany
[3] Fukujuji Hosp, Japan AntiTB Assoc JATA, Div Clin Res, 3-1-24 Matsuyama, Tokyo, Japan
基金
美国国家卫生研究院;
关键词
Epidemiology; Nontuberculous mycobacteria; Mycobacterium avium; Mycobacterium abscessus; Pulmonary disease; Global; Exposome; ENVIRONMENTAL RISK-FACTORS; LUNG-DISEASE; CLINICAL-FEATURES; UNITED-STATES; PUBLIC-HEALTH; RESPIRATORY SPECIMENS; PREVALENCE; AVIUM; INFECTION; TUBERCULOSIS;
D O I
10.1016/j.ccm.2023.08.012
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
NTM-PD and NTM pulmonary isolation are increasing in most countries and regions globally. Isolate-based analysis in several countries indicates distinct trends by NTM species, highlighting the need for more species-specific analyses in NTM epidemiology. Available data regarding spe-cies indicates that MAC continues to predominate in most regions, although in Ontario, Canada, and distinct European countries M kansasii, M xenopi, and M malmoense are found with greater fre-quency. Variation in methods and case definitions limit comparisons across countries and regions. Population-based data including incidence and/ or prevalence are available from North America, Europe, East Asia (Japan, South Korea, and Taiwan), and Queensland, Australia. Studies from Central and South America, Africa, China, the Mid-dle East, and South Asia (India) among patients with suspected TB and MDR-TB are important to document the burden of undiagnosed NTM in this population and ensure appropriate treatment. This highlights the need for enhanced mycobacte-rial laboratory capacity to discriminate between cases of TB and NTM by routine speciation of mycobacterial isolates. Clinical data available from several regions have allowed better charac-terization of the affected populations. Across regions, the majority of cases occur among per -sons aged older than 50 years. In North America and East Asia, the proportion with COPD is typi-cally less than 20%, whereas in Europe, the pro-portion with COPD is higher, above 30% in 9 of 13 studies with this information. Implementation of surveillance systems with standard case definitions is needed to allow for global comparison of prevalence and trends. Cur-rent data where NTM-PD is a notifiable condition have shown the importance and utility of these surveillance data. In particular, timely notification data have allowed inference of the incubation period for infection and disease and have further allowed identification of specific high-risk environ-mental niches and environmental risk factors.
引用
收藏
页码:675 / 721
页数:47
相关论文
共 50 条
  • [21] Changing epidemiology of nontuberculous mycobacterial lung disease in South Korea
    Lee, Sang Kook
    Lee, Eun Ja
    Kim, Se Kyu
    Chang, Joon
    Jeong, Seok Hoon
    Kang, Young Ae
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2012, 44 (10) : 733 - 738
  • [22] The Association between Behavioral Risk Factors and Nontuberculous Mycobacterial Pulmonary Disease
    Park, Youngmok
    Kwak, Se Hyun
    Yong, Seung Hyun
    Lee, Su Hwan
    Leem, Ah Young
    Kim, Song Yee
    Lee, Sang Hoon
    Chung, Kyungsoo
    Kim, Eun Young
    Jung, Ji Ye
    Park, Moo Suk
    Kim, Young Sam
    Chang, Joon
    Kang, Young Ae
    YONSEI MEDICAL JOURNAL, 2021, 62 (08) : 702 - 707
  • [23] Epidemiology of Pulmonary Nontuberculous Mycobacterial Sputum Positivity in Patients with Cystic Fibrosis in the United States, 2010-2014
    Adjemian, Jennifer
    Olivier, Kenneth N.
    Prevots, D. Rebecca
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2018, 15 (07) : 817 - 826
  • [24] Epidemiology of nontuberculous mycobacterial pulmonary disease in Europe and Japan by Delphi estimation
    Schildkraut, Jodie A.
    Gallagher, Jack
    Morimoto, Kozo
    Lange, Christoph
    Haworth, Charles
    Floto, R. Andres
    Hoefsloot, Wouter
    Griffith, David E.
    Wagner, Dirk
    van Ingen, Jakko
    RESPIRATORY MEDICINE, 2020, 173
  • [25] Diagnosis and evaluation of nontuberculous mycobacterial pulmonary disease
    Kim, Hyung-Jun
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2024, 67 (01): : 12 - 18
  • [26] The impact of adjuvant surgical treatment of nontuberculous mycobacterial pulmonary disease on prognosis and outcome
    Fukushima, Kiyoharu
    Miki, Mari
    Matsumoto, Yuki
    Uda, Emi
    Yamamoto, Yuji
    Kogita, Yuya
    Kagawa, Yuko
    Matsuki, Takanori
    Kagawa, Hiroyuki
    Oshitani, Yohei
    Motooka, Daisuke
    Tsujino, Kazuyuki
    Yoshimura, Kenji
    Miki, Keisuke
    Hayashi, Akio
    Nakamura, Shota
    Kitada, Seigo
    Takeuchi, Yukiyasu
    Kida, Hiroshi
    RESPIRATORY RESEARCH, 2020, 21 (01)
  • [27] Nontuberculous mycobacterial pulmonary disease diagnosed by two methods: a prospective cohort study
    Kim, Hyung-Jun
    Lee, Jong Hyuk
    Yoon, Soon Ho
    Kim, Sung A.
    Kim, Myoung Sil
    Choi, Sun Mi
    Lee, Jinwoo
    Lee, Chang-Noon
    Han, Sung Koo
    Yim, Jae-Joon
    BMC INFECTIOUS DISEASES, 2019, 19 (1)
  • [28] Pathophysiology of pulmonary nontuberculous mycobacterial (NTM) disease
    Matsuyama, Masashi
    Matsumura, Sosuke
    Nonaka, Mizu
    Nakajima, Masayuki
    Sakai, Chio
    Arai, Naoki
    Ueda, Kodai
    Hizawa, Nobuyuki
    RESPIRATORY INVESTIGATION, 2023, 61 (02) : 135 - 148
  • [29] Epidemiology of Nontuberculous Mycobacteriosis
    Adjemian, Jennifer
    Daniel-Wayman, Shelby
    Ricotta, Emily
    Prevots, D. Rebecca
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 39 (03) : 325 - 335
  • [30] Nontuberculous mycobacterial pulmonary disease: an increasing burden with substantial costs
    Prevots, D. Rebecca
    Loddenkemper, Robert
    Sotgiu, Giovanni
    Migliori, Giovanni Battista
    EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (04)